Xiang Liao
Directeur/Membre du Conseil chez CLOVER BIOPHARMACEUTICALS, LTD.
Fortune : 15 185 $ au 31/05/2024
Postes actifs de Xiang Liao
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Directeur/Membre du Conseil | 19/04/2021 | - |
| Independent Dir/Board Member | 19/04/2021 | - | |
| Novastream Biotech Co. Ltd. | Directeur Général | 01/03/2012 | - |
Historique de carrière de Xiang Liao
Anciens postes connus de Xiang Liao
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Corporate Officer/Principal | 01/05/1992 | 01/12/2007 |
Formation de Xiang Liao
| West China University of Medical Sciences | Undergraduate Degree |
| University of Scranton | Graduate Degree |
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
Statistiques
Internationale
| Chine | 4 |
| Etats-Unis | 3 |
| France | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Novastream Biotech Co. Ltd. | |
Sanofi Pasteur
Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Health Technology |
- Bourse
- Insiders
- Xiang Liao
- Expérience
